LUXPHARMA: Pharmaceuticals Marketed in Luxembourg

S76 | LUXPHARMA is a list of pharmaceuticals authorized for the Luxembourg market, published by the national health fund (Caisse Nationale de Santé, CNS). Randolph R. Singh and colleagues mapped the drug names to chemical structures using the U.S. EPA's CompTox Chemicals Dashboard. The dataset provides a structured link between regulatory listings and computational toxicology resources for environmental and pharmacological research.

Use Cases

• [Analyzing environmental exposure] based on [mapped chemical structures of marketed drugs]
• [Cross-referencing national drug formularies] based on [the official CNS publication list]
• [Supporting computational pharmacology studies] based on [the linkage between drug names and standardized chemical identifiers]

Strengths

• Provides a formalized mapping from regulatory drug names to computable chemical structures via the authoritative CompTox Dashboard.
• Has a persistent digital object identifier (DOI: 10.5281/zenodo.4587355) for citation and archival stability.
• Derives from an official public health source (CNS Luxembourg), ensuring the core list's authenticity.

Limitations

• Key metadata such as row count, specific column names, and file format are not provided in the available sources.
• The original data source's update frequency is unknown, which may affect the list's currentness.
• The dataset's scope is limited to the Luxembourg market, which may restrict broader geographical analyses.

Provenance

Source

Caisse Nationale de Santé (CNS) Luxembourg; processed by Randolph R. Singh (University of Luxembourg).

Collection Method

Drug names were extracted from the official CNS publication and programmatically mapped to chemical structures using the CompTox Chemicals Dashboard.

Geography

Luxembourg